Especially useful for treating brain cancer and aneurysms
Enjoy your moment smartwatches, it may be briefer than you think
Chronic pain costs the U.S. $635 billion per year
Shown to be 96 percent accurate
From the November issue of HCB News magazine
Will provide access to 3T MR and MR-guided focused ultrasound
How will this impact physicians' treatment decisions?
Only imaging device approved to diagnose early liver disease
From the November issue of HCB News magazine
Clinical decision support systems need to be modified
Bringing “smart hospitals” to life
Speed and ease of use meet XR-29 compliance
Holds promise in treating brain tumors, Parkinson’s, Alzheimer’s and more
U.S. closer to a domestic commercial supply of the SPECT workhorse isotope
Proposed six percent cuts could have shut down many freestanding clinics
Upgrading your radiography equipment is a major undertaking - but it's worth it
Faster acquisition may allow for 100 more scans annually
Over 400 retail medical clinics will be upgraded
Acquisition includes $156.3 million in debt and the promise of new investments
Over two-thirds of U.S. adults are overweight or obese
The future of CR and DR detectors
Part of strategic vision for greater U.S. presence
Funding will more than triple the number of PET/MR systems in UK
A 'breakthrough' in merging neurosurgical robotics and intraoperative imaging
Over 70 percent of people surveyed would let doctors see postings
But... do they actually use them?
Active surveillance surprisingly inexpensive
Will begin with CT algorithm to assess risk of Osteoporosis
Range of potential from skin conditions to heart failure
New drug candidates are showing promise
Will pursue further strategic opportunities with VHA-UHC Alliance
Could have future implications for chemotherapy
He sees “great untapped potential” in IMRIS technology
“Ugh, having an MRI is like being inside a pissed-off fax machine!”
A conversation with CEO Stephen Spotts
Clinical trials illustrate viable alternative to open skull surgery
Another salvo has been fired in the ongoing debate about routine mammography screening
Molecular breast imaging gets its first set of wheels
People, conversely, are “notoriously bad” at it
